RPhLink.com  The Pharmaceutical Care Network!

From: CAROLINA PHARMACEUTICALS

04/15/2004

          Carolina Pharmaceuticals, Inc. feels obliged to correct misinformation that you may have received concerning the relulatiory status of Humibid LA and Humibid DM.  The old formulation of Humibid LA was removed from the market in October 2003 at the direction of the FDA.  The new formulation has not been removed fro the market and these products are currently available at pharmacies nationwide.  Carolina Pharmaceuticals, Inc stands behind these products and wants to assure customers that the FDA has not called into questions the safety of its products.

           While we acknowledge that we recently received a warning letter from the FDA regardomg tje regulatory status of these products, we are scheduled to meet with the FDA next week to address the Agency's questions concerning our products Humbid LA and Humbid DM.  We are confident that we can reach a mutually agreeable resolution of this matter with the FDA and will keep you informed regarding the outcome of this meeting.

            Please note that there have been no reports of confusion in the marketplace concerning the re-formulation of Humibid LA and Humibid DM.  Our product labels and promotional materials clearly identify that Humibid LA and Humibid DM have been reformulated.  Most importantly, there have been no reports to date, of adverse events associated with Humibid LA and Humibid DM.

             Carolina Pharmaceuticals, Inc. is committed to providing our customers with safe and effective, high quality and good value pharmaceutical products.  We appreciate your support and your business.

             Please contact me at (919) 462-0565 if you have any additional questions regarding Humibid LA, Humibid DM, or any other Carolina Pharmaceuticals productl

Sincerely

Craig Collard
President & CEO

Carolina Pharmaceuticals, Inc.

 

RPh of the month: Tunde Adebogun 

In Pharmacy this week!  Did you Know?

Top News:

 

 

Submit a Pharmacy Related Book Review!

Pharmacy Industry News

10/15/03 Wellpoint Pharmacy Management Implimentation of NCPDP 5.1

10/08/03 Urgent! Health Freedom under Fire

09/20/03 Avandia now indicated for use with insulin

08/29/03 The California Pharmacists Association (CPha) Educational Foundation is thrilled to provide exhibit information for outlook 2004.

08/01/03 VersaPharm announces the availability of the new 8 ounce size bottle of the Aminocaproic Acid oil solution USP 25%.

07/14/03 Drug note on Risperdal M-Tab. The convenient formulation of a medication you trust.

07/07/03 New Cardizem LA brings advanced technology to trusted, reliable antihypertensive control.

07/06/03 Metoprolol Protocol following Myocardial Infarction

06/09/03 EPIVIR® now available in 300mg tablets, reduces your patients pill burden.

05/28/03 A Pharmacy Golf Foursome with Tiger Woods.

Professional Education

4/15/03   I am a Physician in Anesthesiology looking for a research project. Considering looking at Keppra for other than label indications. Ie. Low back pain control. Please help me with any ideas, lit search etc. Thanks, Dr. Nicki Tarant  Dept. of Anesthesia Naval Medical Center San Diego

2/04/03 From Hampton University- My enthusiasm for the pharmacy profession.

From AstraZeneca - Product Discontinuation Notice of Rhinocort Nasal Inhaler (NDC#0186-1075-09) 11/20/02

Neurontin® is now indicated for the management of Postherpetic Neuralgia (PHN) in adults 10/25/02

Pharmacy Business Support

10/15/03 Aetna Pharmacy Management  on HIPPA

10/02/03 Round Table Group Consulting opportunity for Expert in Pharmacy Benefits Managers.

09/20/03 C. E. from Biovail.. Hypertension Management update and Counseling Strategies: Addressing the morning Plood Pressure Surge...

9/01/03 Wyeth wishes to inform you, that Safety and Efffectiveness in pediatric patients have not been established with Effexor® and Effexor® XR.

NEBS - Celebrating over 50 years of serving small business. 08/09/03

Ritalin LA Optimized  Start Patient Program 07/27/03

Pharmacy Management & Rx Productivity

03/29/03 Hope for Relief from Fibromyalgia by T.S. Gaginella,Ph.D., RPh, RPhLink V.P. of Clinical Pharmacy Services.

03/23/03 Eli Lilly and Company is proud to announce the availability of Forteo®

03/23/03 FDA approval has been granted for Humira®

02/19/03 "I intend to transform the face of Pharmacy"

TOP Rx News The F. Dohmen Co. and Partners in Pharmacy Cooperative Announce Plan to Expand Dohmen Distribution Partners Business Model into Midwest. 01/15/03

Pharmacy Discussion Board | Focalin dosing flexibility with just the effective isomer.7/15/02

Rx Insurance Info News from PBMs | from Merck-Medco|Express Scripts, Inc. conducts periodic quality assurance pharmacy audits on the behalf of Excellus Health Plan 6/02 | News from Anthem Prescription Management | from AdvancePCS Clozaril Alert! 06/02/02

Daily Pharmacy Product Information Updates

10/16/03 Immediate Attention Required Dispensing Error Alert

09/23/03 Something New on Prescriptions: Look for the "Lo" in Ortho Tri-Cyclen® Lo.

09/04/03 The label for Evista has not changed

08/28/03 Metadate CD 20mg - 100 count bottle for ADHA Patients 6 and older  Once-daily Metadate® CD

07/07/03 Elidel Announcing the availability of Elidel 60g tube.

06/16/03 Novartis Opththalmics would like to inform you about a National Direct-to-consumer campaign for Zaditor®

06/15/03 Vial defect in Accu-check®, Comfort Curve® and Advantage® Test Strips

06/10/03 Raising Public awareness of deep vein thrombosis (DVT)

05/30/03 A trusted name in women's healthcare, announces the launch of Femring® (estradiol acetate vaginal ring).

05/05/03 New information shows that stimulant therapy in children with ADHD may help reduce the risk for future substance use disorder.

Pharmacy Press Releases | CPMP issued a positive reaffirming the favorable risk / benefit Profile of Meridia® (sibutramine) capsules for the treatment of obesity 07/15/02

Drug Information Drug Search | Health | Advicor  ASTRx  Acyclovir  Ritalin LA

Medical Journals Books on line | Disease State Management info

Patient Care Resources to Improve Compliance

Pharmacist's Code of Ethics

New Rx Jobs Posted

Submit a Pharmacy Story

Temporary Pharmacy Jobs

Pharmacy Legislative News

Legislative Alert News!

06/02/03 McNeil Consumer & Specialty Pharmaceuticals is proud to introduce new Flexeril 5mg...

06/01/03 Aminocaproic Acid

03/30/03 OPTIVAR has a new home

02/26/03 Backed by an extensive support program

01/23/03 New Kytril oral solution.

Pliva d.d., Croatia. acquired Sidmak Lab and Odeyssey Pharmaceuticals 10/09/02

Ethex Prenatal Family Adhesive! 10/09/02

Bristol-Meyer Squibb announcing a New indication for Plavix. 10/09/02

Article Submissions for Online RPhLink.com or RPhLink Pharmacy Magazine publications.

MRxI Corporation The Professional Pharmacy Technician Program

Call us at 1-877-RPhLink for our success stories and our client portfolio.

Upcoming Events for Pharmacists and Pharmacy Techs.. 2003

 

 

09/13/04

From: Novartis

Distribution Changes for Lamprene

Pharmacist:

As a regular dispenser of Lamprene (clofazimine), you may already be aware that Novartis has joined with the World Health Organization (WHO) to eradicate leprosy. As part of this commitment, we will provide Lamprene free of charge to patients around the world.

In the United States, our partner in this effort is the National Hansen's Disease Programs (NHDP), a unit of the US Department of Health and Human Services, based in Baton Rouge, Louisiana. When US wholesalers, pharmacy chains and individual pharmacies deplete their inventories of Lamprene later this year, the product will no longer be sold in pharmacies and will only be distributed under an Investigational New Drug (IND) application held by NHDP.

Beginning approximately July 1, 2004, or whenever you can no longer acquire Lamprene through your normal supplier, any requests that you receive for Lamprene for the treatment of leprosy should be directed to :

Renee Painter

Administrative Officer

Laboratory Research Branch

RPAINTI@LSU.EDU

Skip Bertman Drive

Baton Rouge, LA  70803

Phone: 225-578-9861

Fax: 225-578-9856

To receive Lamprene for use in the treatment of leprosy, a physician will need to register as an investigator under the IND held by NHDP. Ms. Painter will provide physicians with the necessary paperwork for this process.

In addition, the FDA has requested that Lamprene be available for the treatment of multi-drug resistant tuberculosis (MDRTB). For this purpose, Lamprene will be distributed via single patient INDs administered by the Food and Drug Administration (FDA). All requests for use of Lamprene (clofazimine) for the treatment of MDRTB must be directed to:

Division of Special Pathogen and Immunologic Drug Products (HFD-590)

Center for Drug Evaluation and Research

Food and Drug Administration

301-827-2127

Upon Approval of the patient IND, the FDA will request NHDP to distribute Lamprene directly to the Prescriber.

If you have any questions about this process, please contact Novartis at 1-888-NOW-NOVA between 9:00AM and 5:00PM Eastern Standard Time, Monday through Friday

Sincerely,

Stephen Cunningham, MD

Vice President and Head

US Clinical Development & Medical Affairs

Novartis Pharmaceuticals Corporation

 

   The #1 Link to Great Pharmacy Events! 

01-16-2005

By: E. R. Doctor of Pharmacy Candidate 2007  -  Washington State University

As a country that once enjoyed free enterprise silently succumbs to the rule of giant corporations, providing an acceptable level of care is becoming increasingly difficult for the pharmacist. Pharmacy students are graduating with large debts that are hard to pay off without surrendering their careers to a nationwide chain that cares less about the patients than the bottom line. These corporations see patients as mere consumers and enact policies that force their pharmacists to do the same. Fortunately, pharmacy is one of the few fields in which the independent businessman still has a fighting chance. I have had several experiences that have inspired me to pursue my goal of self-employment in retail pharmacy. That will enable me to work free of corporate policies that would otherwise compromise my service.

Growing up in the small farming community of Ritzville, Washington, I was inspired at an early age to become a pharmacist. The only pharmacy in our town was independent and the owner was a friend of my family. As I grew up, I saw what an integral part of the community he was. He was always friendly and offered his services with a genuine caring attitude that I have yet to see in any other profession. He was well respected by the community, and people came from miles out of town to get their prescriptions at this store.

During my second year of pharmacy school, I was fortunate enough to attend the National Community Pharmacists Association (NCPA) convention where I learned about the various opportunities available to a pharmacist in the retail setting. During the convention, I conversed with several pharmacy owners from various locations around the country. Some were from large cities like Chicago and Boston. Others were from small towns like the one in which I grew up. Despite their diverse backgrounds, they all shared the same passion for their work.

As an intern, I have worked in two pharmacies so far, one independent and one run by a nationwide chain. The large chain for which I worked only hired a skeleton crew to run its store, often forcing one lone pharmacist to take on over two hundred prescriptions each day. Without much of a supporting staff, the store had gained a reputation for poor service throughout the town. Most of the patients we saw were forced by their insurance companies to buy their prescriptions from us. They were the victim of a deal made between the two corporations that made us a "preferred provider". My internship ended when the district manager decided to eliminate several internship positions in our area to help improve the district's financial situation.

As bad as this experience was, it failed to turn me off to retail pharmacy. I realized that, despite these corporate problems, there were many aspects of my job that I enjoyed. My preceptor was wonderful. She has done all she could to give me a good experience. I had also enjoyed the patient interaction. I decided to try to find a job in a store similar to the one I remembered back home. That week I drove over five hundred miles searching out independent pharmacies in the area. As I applied to stores throughout the area, I was amazed at the diversity. Each one specialized in a niche market in order to compete with the larger chains.

I decided on an internship at an independent pharmacy located in a medical center. Working for an independent pharmacy was a wonderful experience. Even though the daily prescription count was comparable to that of a chain, the staff was much bigger. There was usually more than one pharmacist working and plenty of technicians to keep the store running smoothly. All of the regular patients were on a first name basis with the staff. I saw them receive a level of care that was beyond comparison. Many even commented about our service being better than the other pharmacies in town. My preceptor was able to spend more time with me, teaching me about counseling patients, quizzing me about drugs, and answering all my questions about ownership and management. My experience was further enhanced by the pharmacy's location in a large Medical Center. Doctors who were good friends with my preceptor would come down to chat. This gave me exposure to a variety of professionals in the medical field.

These experiences have inspired me to become an advocate for independent business, especially in pharmacy. When I graduate, I will continue this advocacy by seeking out a job in a locally owned, community pharmacy. After graduation, I will continue to be active in organizations that help independent pharmacies through legislation and networking. One day, when I have gained enough experience to take on the challenge, I hope to become a pharmacy owner. Throughout my career, I will do my best to provide to my patients the same level of service that I have seen in independent pharmacies so far.

 

 


General Pharmacy Classified | Pharmacy Antiques | Pharmacy Collectibles | Pharmacy Archives      

RPhLink.com |Front page | In Pharmacy this week | RxNews1 | RxNews2 | Pharmacy Jobs |

Back to previous page    |    More News from Aetna    |    year  2003 | 2002

RPhlink® is a Pharmacy Management, Pharmacy Consulting, Pharmacy Placement & Staffing Firm

© 1996-2006 RPhLink.com  The Pharmaceutical Care Network! is designed and published by RPhLink. Inc. All Rights Reserved. 

RPhLink.com is designed by RPhs for Pharmacists & Pharmacy Techs.  For information use only! Disclaimer.